FOXO1 is a tumor suppressor in classical Hodgkin lymphoma

Linka Xie, Alexey Ushmorov, Frank Leithäuser, +9

Blood

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

Hanfeng Guan, Linka Xie, Frank Leithäuser, +3

Blood

Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer

Jie You, Gui‐Qi Zhu, Linka Xie, +7

Oncotarget

AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion

Yuxi Ma, Zihan Xia, Chunmei Ye, +10

Aging

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

Marion Vogel, Linka Xie, Hanfeng Guan, +17

Blood

FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC

Peng Tan, Hanfeng Guan, Linka Xie, +4

Scientific Reports

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling

Zhao Liu, Chen Mi, Linka Xie, +8

Aging

Epithelial-mesenchymal TransitionEmt MarkersChloride Channel A4Signaling PathwayTumor Microenvironment +12

Decitabine represses translocated <i><scp>MYC</scp></i> oncogene in Burkitt lymphoma

Hanfeng Guan, Linka Xie, Kay Klapproth, +3

The Journal of Pathology

ImmunologyPathologyCancer BiologyEpigeneticsTumor Biology +17

Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation

Clarissa D. Osswald, Linka Xie, Hanfeng Guan, +8

Blood

FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma

Linka Xie, Olga Ritz, Frank Leithäuser, +10

Oncotarget